1. Walzer, P.D. (1994) Pneumocystis carinii Pneumonia, 2nd edn., Marcel Dekker, Inc., New York.
2. Cushion, M.T. (1998) Pneumocystis carinii, in Topley and Wilson's Microbiology and Microbial Infections Medical Mycology (Collier, L.A., and Sussman, M., eds.), 9th edn., Vol. 4, pp. 645–683, Arnold Publishers, Oxford University Press, New York.
3. Mercer, E.I. (1991) Sterol Synthesis Inhibitors: Their Current Status and Modes of Action, Lipids 26, 584–597.
4. Guo, D., Mangla, A.T., Zhou, W., Lopez, M., Jia, Z., Nichols, S.D., and Nes, W.D. (1997) Antifungal Sterol Biosynthesis Inhibitors, in Cholesterol: Its Functions, and Metabolism in Biology and Medicine (Bittman, R., ed.), Subcell. Biochem. 28, 91–116.
5. Kaneshiro, E.S., Ellis, J.E., Jayasimhulu, K., and Beach, D.H. (1994) Evidence for the Presence of “Metabolic Sterols” in Pneumocystis: Identification and Initial Characterization of Pneumocystis carinii Sterols, J. Eukaryot. Microbiol. 41, 78–85.